Join us at KassenGipfel 2022!

Within the framework of the KassenGipfel 2022, FUTURE PROOFING MEDICINES will take place as a satellite event moderated by Carlos Härtel, the Chairman of the Board of Directors at Science|Business.


The EU’s new pharmaceutical strategy recognises that secure, affordable and efficient access to new therapeutics and devices will play a key role in strengthening post-pandemic health systems, improving outcomes for patients, and sustaining the global competitiveness of European firms in various health sectors. Policymakers at the EU and national levels also acknowledge the need for new methods of evidence generation and assessment, such as analysis of big and real-world data, to support the development, authorisation, and use of medicines.

In parallel, scientists are making rapid strides toward the next generation of medicines, in areas such as cell- and gene-based therapies and genomics, while advanced computing, AI, common data spaces and more are pushing back the boundaries of what data science can achieve. As the EU moves forward with its new strategy and landmark revision of its basic pharmaceutical legislation, a vital question is how regulation can anticipate and accommodate these scientific and technological breakthroughs, foster innovation, and remain flexible to future health crises, policy priorities and the concerns of major stakeholders.

Against this backdrop, Science|Business – Europe’s leading media organisation specialised in R&I policy issues – is partnering with EIT Health and others to stage high-level dialogues in various EU capitals to gather national perspectives on this issue (under what we call the Future Proofing Medicines initiative).

The September 28/29 meeting in Berlin is an opportunity for German health sector leaders to present their views on the future of medicines regulation, its potential impact on industry and society, and how the power of medical science, health data and digital innovation can be fully harnessed in the years to come.  It will be the second high-level meeting of the Future Proofing Medicines initiative, bridging between an expert roundtable in Copenhagen (June 2022) and a public conference in Stockholm (Q1 2023) during the Swedish Presidency of the European Council.



Economic and financial environment/capitalization and financing of healthcare services

  • Sword of Damocles: 30 billion deficit
  • Reform of the DRG system: For a sustainable hospital landscape
  • Outpatient versus inpatient – equal remuneration for equal performance

Political, legal, fiscal and regulatory framework conditions

  • Health policy 2021-2025 – The health policy plans of the new government
  • Health Care Expansion Act (GVWG)
  • Digital Care and Nursing Modernization Act (DVPMG)
  • Hospital Future Act (KHZG)
  • Intensive Care and Rehabilitation Strengthening Act (IPReg)
  • Patient Data Protection Act (PDSG) – Does data protection hinder system innovation?
  • The future of orphan drugs in Germany

The resilience and innovative capacity of the German healthcare system put to the test

  • Shortage of physicians and nursing shortages: Security of supply at risk
  • Health workforce – social, economic and political challenge
  • Recruitment of specialists from abroad
  • Nursing workforce assessment tool (PPR 2.0)

Sustainability in healthcare: Green Healthcare Health DIGITAL – 2025

  • Telemedicine, DiGAs, AI, Big Data, IT infrastructure, health data governance, population health management
  • New players and smart solutions


You can meet the following experts:

Nick Schneider
Head of the New Technologies and Data Use, BMG

Prof. Freimut Schliess
Member of the Supervisory Board, EIT Health

Valerie Kirchberger
Chief Medical Officer & Managing Director, heartbeat medical

Dr. Christoph Löschmann
Chairman of the Board, Gesundes Kinzigtal GmbH

Dr. Michael Alain Lüttgen
Stakeholder Relations Lead, EIT Health Germany GmbH


Prof. Dr. Dr. Alexander P. F. Ehlers
Specialist in medical law, specialist in general medicine, Ehlers & Partner

Dr. Katharina Ladewig
Managing Director Centre for AI, RKI


Participation fees

Face-to-face event:
The participation fee for the two-day event including conference documents, an invitation to dinner, lunch, drinks during breaks and small snacks is per person: € 1.995,-.

  • Special price for employees (§59 HGB) from GKV and PKV as well as health associations in the amount of: € 1.295,-.
  • Special price for employees (§59 HGB) from rehabilitation facilities, hospitals and physicians in private practice in the amount of: € 895,-.
  • Buy 2 – Get 3! If you register three people from one company, you will receive a free ticket for the third person. (Only valid for the face-to-face event).

Online event:
The participation fee for the two-day event incl. conference documents is per person: € 795,-.

  • Special price for employees (§59 HGB) from GKV and PKV as well as health associations in the amount of: € 595,-.
  • Special price for employees (§59 HGB) from rehabilitation facilities, hospitals and practising physicians in the amount of: € 495,-.


Would you like to find out more about the event? Visit the website of the event or download the brochure here.

Register now for the event!